Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.84 CAD | +13.60% | +25.11% | +5.19% |
25.06. | NervGen Pharma bringt neuen Medikamentenkandidaten in präklinisches Proof-of-Concept-Stadium | MT |
05.06. | NervGen Pharma Corp. genehmigt die Wahlen zum Vorstand und Prüfungsausschuss | CI |
5-Tages-Kurse
verzögerte Kurse Toronto S.E.21.06.2024 | 24.06.2024 | 25.06.2024 | 26.06.2024 | |
---|---|---|---|---|
Kurs | 2.3 $ | 2.42 $ | 2.5 $ | 2.84 $ |
Volumen | 14 208 | 98 107 | 156 536 | 117 936 |
Veränderung | +0.88% | +5.22% | +3.31% | +13.60% |
Eröffnung | 2.26 | 2.30 | 2.44 | 2.50 |
Hoch | 2.30 | 2.48 | 2.61 | 2.90 |
Tief | 2.22 | 2.26 | 2.38 | 2.47 |
Performance
1 Tag | +13.60% | ||
1 Woche | +25.11% | ||
Aktueller Monat | +45.64% | ||
1 Monat | +37.86% | ||
3 Monate | +37.86% | ||
6 Monate | +37.20% | ||
Laufendes Jahr | +5.19% | ||
1 Jahr | +77.50% | ||
3 Jahre | +77.50% | ||
5 Jahre | +94.52% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Biotechnologie und medizinische Forschung - Andere
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
+13.60% | +25.11% | +5.19% | +77.50% | 145 Mio. | ||
-2.19% | -8.12% | +23.13% | +1.69% | 46.93 Mrd. | ||
-0.25% | +0.87% | +37.07% | -5.97% | 39.08 Mrd. | ||
-0.79% | -0.78% | -8.73% | -1.23% | 38.48 Mrd. | ||
+0.17% | +59.35% | +28.09% | +28.13% | 31.01 Mrd. | ||
-0.90% | -3.60% | -12.26% | +7.09% | 26.14 Mrd. | ||
-0.32% | -1.77% | +10.57% | +36.84% | 25.88 Mrd. | ||
+0.42% | +0.58% | +32.23% | +80.06% | 12.53 Mrd. | ||
-1.24% | -3.27% | -6.56% | -6.11% | 11.36 Mrd. | ||
-0.39% | -1.47% | -12.56% | +0.20% | 10.65 Mrd. | ||
+0.76% | -6.90% | -9.03% | -12.61% | 9.04 Mrd. | ||
-0.36% | +17.37% | -5.71% | +21.99% | 6.96 Mrd. | ||
+1.82% | +3.07% | +26.62% | +9.73% | 6.76 Mrd. | ||
-0.36% | -2.61% | +12.66% | +65.69% | 6.51 Mrd. | ||
-0.81% | +1.86% | +33.96% | +54.48% | 6.34 Mrd. | ||
-.--% | -.--% | - | - | 6.07 Mrd. | ||
Durchschnitt | +0.56% | +5.28% | +10.31% | +23.83% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | -0.60% | +5.22% | +12.87% | +13.08% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | +5.19% | ||
2023 | +68.75% | ||
2022 | -41.39% | ||
2021 | +22.42% | ||
2020 | +13.78% | ||
2019 | +12.64% |
- Börse
- Aktien
- A2QP3D Aktie
- Kurse NervGen Pharma Corp.